![](/img/cover-not-exists.png)
Phase I/II dose-escalation study of liarozole in patients with stage D, hormone-refractory carcinoma of the prostate
E. James Seidmon, Donald L. Trump, Willi Kreis, Stephen W. Hall, Michael R. Kurman, S. Peter Ouyang, Jane Wu, Alton B. KremerVolume:
2
Language:
english
Pages:
7
DOI:
10.1007/bf02307090
Date:
November, 1995
File:
PDF, 816 KB
english, 1995